News Article | May 10, 2017
"Emerus and Memorial Hermann share a common goal to provide innovative, high quality, patient-centered care to those who need it most," said David Bradshaw, Executive Vice President and Chief Strategy Officer at Memorial Hermann. "We're excited to join Emerus in this new care delivery venture that will help us continue to improve our community's access to that care by offering convenient locations throughout the city that are easy to get to, no matter where you live." Emerus opened its first micro-hospital in Tomball 11 years ago, followed shortly thereafter by the Sugar Land location. Until now, the two Houston locations were the only Emerus facilities not affiliated with a major health system. The Emerus Community Hospital, located at 24429 Tomball Parkway in Tomball, will be renamed Memorial Hermann Tomball Hospital; and the Emerus 24HR Emergency Hospital, located at 16000 Southwest Freeway, Suite 100, in Sugar Land, will be renamed Memorial Hermann First Colony Hospital. Uniquely different from urgent care clinics, Emerus facilities provide emergency centers with additional services such as primary care, diagnostic imaging, and lab tests – in a smaller, more efficient footprint, with shorter waiting times and convenient parking, closer to patients' neighborhoods and homes. These new facilities will expand the already well-established Memorial Hermann emergency care network to 19 locations including acute care hospitals, Convenient Care Centers and a free-standing emergency room in The Woodlands. Once integrated, these hospitals will feature: Each facility will be staffed by board-certified physicians, experienced nurses and other clinical specialists dedicated to providing the same level of compassionate, patient-centered care found throughout Memorial Hermann Health System. ABOUT EMERUS Emerus is the nation's first and largest operator of micro-hospitals. Emerus partners with leading health systems to provide excellence, empathy and innovation in health care delivery through a network of efficient, value-based micro-hospitals. The Emerus network brings high-quality, patient-centric acute episodic and ambulatory clinical services to communities across a given market. This helps patients by positioning best-in-class provider services in the communities where they work, live and play. Emerus' distinctive level of care earned the Guardian of Excellence Award for Superior Patient Experience in 2013, 2014, 2015 and 2016. More information is available at www.emerus.com. ABOUT MEMORIAL HERMANN A fully integrated health system with more than 250 care delivery sites throughout the Greater Houston area, including a nationally acclaimed Accountable Care Organization, Memorial Hermann is committed to delivering safe, high-quality, patient-centered care and offers world-class clinical expertise, innovation and cutting-edge technology to all patients, including its Health Plan members. The system, with its exceptional affiliated medical staff and more than 25,000 employees, provides compassionate, superior service while advancing health in Southeast Texas. Learn more about Memorial Hermann Health System. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/memorial-hermann-and-emerus-announce-joint-venture-to-improve-access-to-high-quality-care-300455347.html
News Article | April 20, 2017
Dogs share everything with their humans—food, a bed, and now, even weed. Cannabis treats for canines are a growing medicinal trend, especially in places where marijuana is legal. But offering some bud to your bud can present a flurry of ethical dilemmas. Is it okay, I wondered, to get your dog high? I spoke to several experts about the dos and don't of dosing your pets. Their recommendations varied, but all of them agreed on one thing: Blowing smoke in your dog's face is extremely shitty. Guys, never do that. "THC is toxic to dogs, and while it's pretty rare for a dog to die directly from THC intoxication, it's very likely that they'll at least need to spend a day at the hospital receiving supportive care until the full effects wear off," veterinarian Dr. Mark Primiano told me. Some common signs that your pup is stoned are lethargy, excessive peeing, low blood pressure, ataxia (loss of bodily control), and even seizures. If you think your dog got into your stash, it's best to bring them to an emergency clinic right away. "The vet has no obligation to snitch and will be much happier if they're able to just treat your dog for what they know is the problem without having to run a bunch of unnecessary tests," Dr. Primiano added. Some veterinary offices have blamed these accidents on the legalization of marijuana. In Englewood, Colorado, the VRCC Emergency Hospital told ABC News that since the state's passing of medical marijuana laws, it treats several animals per week who have unwittingly eaten edibles. But the decriminalization of weed can be a boon for pet safety, too. I spoke to one San Francisco-based startup that specializes in cannabis tinctures for cats and dogs. Much like the stuff you'd find at a dispensary, TreatWell's products are lab-tested, and marketed as homeopathic medicine for everything from anxiety to cancer. According to Alison Ettel, CEO and founder of TreatWell, dogs would never "freak out or have a bad reaction" to their products, since they're scrupulously formulated and non-psychoactive. "If someone see a negative reaction, it's because [their pet has ingested] hemp or products with pesticides in them. We don't believe in using pure THC," she noted. Instead, TreatWell uses a ratio of THC to CBD (cannabidiol), which is another chemical compound that's found in cannabis, in addition to a cocktail of acids, terpenes, and "sub-cannabinoids." Still, it's important to understand that canine cannabis treats aren't recreational—you shouldn't get your dog blazed just because you think they'd like it. For pets undergoing cancer treatment, or for those with debilitating illnesses, cannabis can be an alternative to pharmaceutical medicine (though it should always be used in tandem with a veterinarian's advice, unless they specify otherwise). Not all doctors will prescribe cannabis, though. That's because there's less scientific research to support its validity as a medical treatment. "If you don't have sound reasoning and examples of proof that your treatment will work (and not just anecdotal evidence), not only are you putting your patient's life and health at risk, you're putting your license on the line," Dr. Primiano said. And then there's issue of consent. Dogs can't tell you, "hey man, I wanna get lit." They also can't tell you how it makes them feel, which is why it's necessary to monitor their behavior after experimenting with cannabis products. Personally, I haven't given any to my dog because of this. When I asked PETA, which is known for its polarizing opinions about the treatment of animals, about this conundrum, Senior Vice President of Cruelty Investigations Daphna Nachminovitch said: "It's no more acceptable to amuse yourself by getting a dog high than it would be by getting a child drunk." What PETA does condone is the use of medical cannabis for palliative care. "Dogs in pain should be given the same consideration that humans in pain are, and if cannabis treats can truly relieve their pain, regular doses would be appropriate to help reduce their misery," Nachminovitch added. As with humans, weed for dogs should ultimately make them feel nice. If you're lucky, and live where marijuana is legal, you can even get your pet its own, personal stash. And by following a few set rules, like not smoking them out, you can ensure that your puppy pal is good to go. Motherboard is nominated for three Webby Awards for Best Science YouTube Channel , Best Drama , Best Tech/Science Podcast. Please vote for us!
News Article | November 18, 2016
SAN ANTONIO, Nov. 18, 2016 /PRNewswire/ -- A free community event and ribbon-cutting ceremony Saturday, Nov. 19, celebrates the newest Baptist Emergency Hospital – NW Military, opening in late November. The nearly 40,000-square-foot emergency center is being built through a...
Aro H.T.,University of Turku |
Govender S.,University of KwaZulu - Natal |
Patel A.D.,Norwich University |
Hernigou P.,Service dOrthopedie et de Traumatologie |
And 5 more authors.
Journal of Bone and Joint Surgery - Series A | Year: 2011
Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) improves healing of open tibial fractures treated with unreamed intramedullary nail fixation. We evaluated the use of rhBMP-2 in the treatment of acute open tibial fractures treated with reamed intramedullary nail fixation. Methods: Patients were randomly assigned (1:1) to receive the standard of care consisting of intramedullary nail fixation and routine soft-tissue management (the SOC group) or the standard of care plus an absorbable collagen sponge implant containing 1.5 mg/mL of rhBMP-2 (total, 12.0 mg) (the rhBMP-2/ACS group). Randomization was stratified by fracture severity. The absorbable collagen sponge was placed over the fracture at wound closure. The primary efficacy end point was the proportion of subjects with a healed fracture as demonstrated by radiographic and clinical assessment thirteen and twenty weeks after definitive wound closure. Results: Two hundred and seventy-seven patients were randomized and were the subjects of the intent-to-treat analysis. Thirteen percent of the fractures were Gustilo-Anderson Type IIIB. The proportions of patients with fracture-healing were 60% and 48% at week 13 (p = 0.0541) and 68% and 67% at week 20 in the rhBMP-2/ACS and SOC groups, respectively. Twelve percent of the subjects underwent secondary procedures in each group; more invasive procedures (e.g., exchange nailing) accounted for 30% of the procedures in the rhBMP-2/ACS group and 57% in the SOC group (p = 0.1271). Infection was seen in twenty-seven (19%) of the patients in the rhBMP-2/ACS group and fifteen (11%) in the SOC group (p = 0.0645; difference in infection risk = 0.09 [95% confidence interval, 0.0 to 0.17]). The adverse event incidence was otherwise similar between the treatment groups. Conclusions: The healing of open tibial fractures treated with reamed intramedullary nail fixation was not significantly accelerated by the addition of an absorbable collagen sponge containing rhBMP-2. Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence. Copyright © 2011 by The Journal of Bone and Joint Surgery, Incorporated.
Gluhovschi G.H.,Emergency Hospital
Romanian journal of internal medicine = Revue roumaine de médecine interne | Year: 2011
Diabetic nephropathy, one of the most important complications of diabetes mellitus, requires during its evolution protective measures defined as renoprotective. Since the complications of diabetes mellitus are not limited to diabetic nephropathy and as this is frequently associated with heart complications that require protective measures defined as cardioprotective, neurologic measures that require neuroprotection of the retina, of the large vessels etc., much more complex protective measures are necessary. The metabolic complications that are usually at the basis of the other complications at the level of the cell also impose measures of protection. Such an approach can have important practical consequences. It is a well-known fact that most patients with chronic kidney disease--CKD--do not reach final stages as in the meantime they decease because of cardiovascular diseases. Consequently, cardioprotective measures have to be associated with renoprotective ones, as well as protective measures that address other organs, in close connection with protective measures at metabolic level. The protective measures must also address to microcirculation, diabetic nephropathy being a disease that primarily affects microcirculation. Diabetes mellitus also frequently affects the large vessels, the circulatory system being usually affected in its complexity. The paper represents a synthesis of multiorganprotective measures in diabetic nephropathy, in diabetes mellitus, respectively, the concept of multiorgan protection finding in this disease an ideal domain of expression. The first part gives the main multiorgan measures: monitoring of blood pressure and, mainly, protection by means of the renine aldosterone (RAAS) system, multiorgan by intensive monitoring of glycaemia and by treatment of proteinuria. The second part presents the other protective measures used in diabetic nephropathy.
Simsekyilmaz S.,RWTH Aachen |
Simsekyilmaz S.,Huazhong University of Science and Technology |
Liehn E.A.,RWTH Aachen |
Militaru C.,Emergency Hospital |
Vogt F.,RWTH Aachen
Thrombosis and Haemostasis | Year: 2015
Cardiovascular disease is the leading cause of death in the western and developing countries. Percutaneous transluminal coronary interventions have become the most prevalent treatment option for coronary artery disease; however, due to serious complications, such as stent thrombosis and in-stent restenosis (ISR), the efficacy and safety of the procedure remain important issues to address. Strategies to overcome these aspects are under extensive investigation. In this review, we summarise relevant milestones during the time to overcome these limitations of coronary stents, such as the development of polymer-free drug-eluting stents (DES) to avoid pro-inflammatory response due to the polymer coating or the developement of stents with cell-directing drugs to, simultaneously, improve re-endothelialisation and inhibit ISR amongst other techniques most recently developed, which have not fully entered the clinical stage. Also the novel concept of fully biodegradable DES featured by the lack of a permanent foreign body promises to be a beneficial and applicable tool to restore a natural vessel with maintained vasomotion and to enable optional subsequent surgical revascularisation. © Schattauer 2015.
Ilie M.,Emergency Hospital
Roumanian archives of microbiology and immunology | Year: 2011
Helicobacter pylori is one of the most common among the numerous bacterial species of the stomach. It is classified as a class 1 carcinogen because of its causal relationship to gastric adenocarcinoma. The epidemiology of H. pylori infection is characterized by a marked difference between developing and developed countries. Treatment of H. pylori still remains a challenge due to the high rate of antibiotic resistance. The aim of this study was to investigate the susceptibility of H. pylori strains isolated from gastric biopsies to different antibiotics currently used in the H. pylori infection treatment schemes. Upper gastrointestinal GI endoscopy was performed, followed by the rapid urease test on gastric biopsies. The positive samples were cultivated on specific media under microaerophilic conditions and the antibiotic susceptibility assay was performed on the isolated strains. A positivity rate of 70% was obtained for cultures performed from the biopsy samples positive for the urease test. The resistance rates for the antibiotics used in the classic triple therapy proved to be high, i.e. 92.8% for metronidazole, 50% for amoxicillin and 32% for clarithromycin. The isolated strains proved to be sensitive to ciprofloxacin and levofloxacin. The role of gastric microbiota and its contribution to the H. pylori associated pathology need to be established. The problem of antibiotic treatment failure in case of resistant H. pylori strains can be surpassed by routine culture and antibiotic susceptibility testings.
Beuran M.,Emergency Hospital
Journal of medicine and life | Year: 2010
Nonoperative management (NOM) of liver trauma is currently rather the rule than the exception. However, the current evidence presents subgroups of patients at higher risk for NOM failure. These patients must be treated more cautiously regarding the NOM approach. A case report of 3 polytrauma patients (Injury Severity Score > 17) with high-degree liver trauma managed nonoperatively. The first case presented is the one of a polytrauma patient with degree IV liver injury and impaired mental status. It was a high risk for NOM failure because there was an angiographically hemostasis. The second case is one of a polytrauma patient who became hemodynamically stable after the administration of 2000 ml of fluid intravenously. There was a nonoperative approach with angiography and embolization of degree IV liver injury. Despite the success of the nonoperative treatment, there was an important hepatic necrosis following embolization. The third case is one of a polytrauma patient with a degree IV hepatic injury. Success was accomplished in NOM without an angiography. Nonoperative management of liver injuries can be applied safely even in high degree hepatic trauma. In hemodynamically metastable patients or impaired mental status patients, the nonoperative approach can be applied successfully, but the trauma surgeon must be very cautious.
Nicolau A.E.,Emergency Hospital
Chirurgia (Romania) | Year: 2011
Introduction: Laparoscopy, as a minimally invasive diagnostic and therapeutic tool in blunt abdominal trauma (BAT), is not commonly used and has been shown to be controversial. The aim of this study is to assess the role of laparoscopy in the diagnosis and therapy of BAT. Methods: A systematic review and a comprehensive literature search was performed at the U.S. National Library of Medicine site in Medline and PubMed from January 2000 to 31 December 2007. This article attempts to outline the efficacy, the indications, contraindications, surgical technique and therapeutic possibilities of laparoscopy in B AT. Pediatric surgery articles and those addressing penetrating abdominal wounds, nontraumatic abdominal emergencies and iatrogenic injuries were excluded from this review. Results: Sixty-six articles were reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines. The reviewed articles comprised 343 patients with BAT and laparoscopic approach. Therapeutic laparoscopy was possible in 168 cases (48,98%), 51 cases were converted (14,87%), overlooked injuries were absent, 6 patients had complications (1,75%), no mortality laparoscopy-related. The main indications for laparoscopy in BAT include the confirmation of suspected diaphragmatic defects, suspected hollow viscus and mesenteric injuries, in patients with inconclusive clinical exams and abdominal imaging. Diagnostic laparoscopy (DL) is also indicated in patients with suspected intra-abdominal injuries when advanced emergency imaging investigations are unavailable. Laparoscopy allows the surgeon to perform hemostasis, resections, suturing, autotransfusion, etc. Conclusion: Although is not widely used, laparoscopy could still be useful in selected patients with BAT who have equivocal findings on clinical exam and imaging investigations in order to clarify the lesional diagnosis, thus avoiding unnecessary laparotomies. Multicenter prospective studies are needed to better assess the role of laparoscopy in blunt abdominal trauma.
Maniu A.,University of Medicine and Pharmacy, Cluj-Napoca |
Damian L.,Emergency Hospital
American Journal of Otolaryngology - Head and Neck Medicine and Surgery | Year: 2013
We report on a patient with Lyme disease who presented with chronic bilateral otitis media and cranial neuropathy with rapid progresive hearing loss. After ceftriaxone and high-dose intravenous immunglobulins, the disease was controlled only with methylprednisolone and cyclophosphamide. The relationship between Lyme disease and granulomatous vasculitis is discussed. Lyme disease should be kept in mind in the differential diagnosis of various otolaryngological and neurological presentations. © 2013 Elsevier Inc. All rights reserved.